{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:49:21Z","timestamp":1793504961659,"version":"4.5.0"},"reference-count":282,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.pharmthera.2026.109016","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:23:40Z","timestamp":1773249820000},"page":"109016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The role of MyD88 in the nervous system: Neuronal functions, implications in neurological diseases, and therapeutic potential"],"prefix":"10.1016","volume":"282","author":[{"given":"Hai-Li","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yi","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Ang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Huan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ni","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo-Jie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Zhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2026.109016_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115711","article-title":"From immunity to neurogenesis: toll-like receptors as versatile regulators in the nervous system","volume":"25","author":"Abarca-Merlin","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbi.2022.02.016","article-title":"Roles of neuronal toll-like receptors in neuropathic pain and central nervous system injuries and diseases","volume":"102","author":"Acioglu","year":"2022","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1074-7613(00)80596-8","article-title":"Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function","volume":"9","author":"Adachi","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057208","article-title":"Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice","volume":"8","author":"Ahmad","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084185","article-title":"Role of adaptor protein myeloid differentiation 88 (MyD88) in post-subarachnoid hemorrhage inflammation: A systematic review","volume":"22","author":"Ahmed","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0030","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41576-023-00592-y","article-title":"Amyotrophic lateral sclerosis: Translating genetic discoveries into therapies","volume":"24","author":"Akcimen","year":"2023","journal-title":"Nature Reviews. Genetics"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0035","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/cbdd.12477","article-title":"Structure-based design and synthesis of a small molecule that exhibits anti-inflammatory activity by inhibition of MyD88-mediated signaling to bacterial toxin exposure","volume":"86","author":"Alam","year":"2015","journal-title":"Chemical Biology & Drug Design"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2009.06.016","article-title":"Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain","volume":"214","author":"Alboni","year":"2009","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0045","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0050","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(85)90275-2","article-title":"Establishment of dorsal-ventral polarity in the Drosophila embryo: The induction of polarity by the toll gene product","volume":"42","author":"Anderson","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0055","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0092-8674(85)90274-0","article-title":"Establishment of dorsal-ventral polarity in the Drosophila embryo: Genetic studies on the role of the toll gene product","volume":"42","author":"Anderson","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-024-00943-2","article-title":"Frameworks for transformational breakthroughs in RNA-based medicines","volume":"23","author":"Androsavich","year":"2024","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2024.101760","article-title":"The penetration of therapeutics across the blood-brain barrier: Classic case studies and clinical implications","volume":"5","author":"Banks","year":"2024","journal-title":"Cell Reports Medicine"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0070","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fnins.2014.00272","article-title":"Toll-like receptors as developmental tools that regulate neurogenesis during development: An update","volume":"8","author":"Barak","year":"2014","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0075","doi-asserted-by":"crossref","first-page":"7971","DOI":"10.1073\/pnas.0932746100","article-title":"A low molecular weight mimic of the toll\/IL-1 receptor\/resistance domain inhibits IL-1 receptor-mediated responses","volume":"100","author":"Bartfai","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yjmcc.2021.08.001","article-title":"MyD88: At the heart of inflammatory signaling and cardiovascular disease","volume":"161","author":"Bayer","year":"2021","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12883-017-0994-z","article-title":"Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis","volume":"17","author":"Beez","year":"2017","journal-title":"BMC Neurology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnins.2011.00080","article-title":"Alpha-Synuclein alters toll-like receptor expression","volume":"5","author":"Beraud","year":"2011","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0095","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1126\/science.1158298","article-title":"Pyogenic bacterial infections in humans with MyD88 deficiency","volume":"321","author":"von Bernuth","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0100","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1021\/jm200113t","article-title":"Novel oligonucleotides containing two 3\u2032-ends complementary to target mRNA show optimal gene-silencing activity","volume":"54","author":"Bhagat","year":"2011","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1742-2094-8-183","article-title":"Interleukin-1 beta and neurotrophin-3 synergistically promote neurite growth in vitro","volume":"8","author":"Boato","year":"2011","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1128190","article-title":"Cause or consequence? The role of IL-1 family cytokines and receptors in neuroinflammatory and neurodegenerative diseases","volume":"14","author":"Boraschi","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/imr.12606","article-title":"The family of the interleukin-1 receptors","volume":"281","author":"Boraschi","year":"2018","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tins.2014.12.006","article-title":"The role of inflammatory cytokines as key modulators of neurogenesis","volume":"38","author":"Borsini","year":"2015","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0125","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.4049\/jimmunol.1601948","article-title":"Activation of myeloid TLR4 mediates T lymphocyte polarization after traumatic brain injury","volume":"198","author":"Braun","year":"2017","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1084\/jem.20021790","article-title":"Inhibition of interleukin 1 receptor\/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4","volume":"197","author":"Burns","year":"2003","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0135","doi-asserted-by":"crossref","first-page":"15112","DOI":"10.1523\/JNEUROSCI.1729-12.2012","article-title":"Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer\u2019s disease","volume":"32","author":"Cameron","year":"2012","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbi.2018.12.003","article-title":"TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson's diseases in vivo model","volume":"76","author":"Campolo","year":"2019","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0145","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1126\/science.271.5252.1128","article-title":"IRAK: A kinase associated with the interleukin-1 receptor","volume":"271","author":"Cao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0150","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/cvr\/cvp234","article-title":"The TIR\/BB-loop mimetic AS-1 protects the myocardium from ischaemia\/reperfusion injury","volume":"84","author":"Cao","year":"2009","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/12623","article-title":"A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation","volume":"23","author":"Carrie","year":"1999","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bcp.2019.01.005","article-title":"SARM: From immune regulator to cell executioner","volume":"161","author":"Carty","year":"2019","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0165","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ni1382","article-title":"The human adaptor SARM negatively regulates adaptor protein TRIF-dependent toll-like receptor signaling","volume":"7","author":"Carty","year":"2006","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0170","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.106.603431","article-title":"Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke","volume":"115","author":"Caso","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072035","article-title":"Role of damage associated molecular pattern molecules (DAMPs) in aneurysmal subarachnoid hemorrhage (aSAH)","volume":"19","author":"Chaudhry","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0180","doi-asserted-by":"crossref","first-page":"169","DOI":"10.15252\/embr.201642586","article-title":"TLR3 downregulates expression of schizophrenia gene Disc1 via MYD88 to control neuronal morphology","volume":"18","author":"Chen","year":"2017","journal-title":"EMBO Reports"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0185","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1021\/acsptsci.3c00254","article-title":"Optogenetic activation of peripheral somatosensory neurons in transgenic mice as a neuropathic pain model for assessing the therapeutic efficacy of analgesics","volume":"7","author":"Chen","year":"2024","journal-title":"ACS Pharmacology & Translational Science"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0190","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2018.09.068","article-title":"Development of 2-amino-4-phenylthiazole analogues to disrupt myeloid differentiation factor 88 and prevent inflammatory responses in acute lung injury","volume":"161","author":"Chen","year":"2019","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0195","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1021\/acs.jmedchem.3c00359","article-title":"Design, synthesis, and bioevaluation of novel MyD88 inhibitor c17 against acute lung injury derived from the virtual screen","volume":"66","author":"Chen","year":"2023","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0200","doi-asserted-by":"crossref","first-page":"22263","DOI":"10.1021\/acs.jmedchem.4c02401","article-title":"Discovery of novel MyD88 inhibitor A5S to alleviate acute lung injury with favorable drug-like properties","volume":"67","author":"Chen","year":"2024","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0205","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41401-020-0487-2","article-title":"Pyrroloquinoline quinone promotes mitochondrial biogenesis in rotenone-induced Parkinson\u2019s disease model via AMPK activation","volume":"42","author":"Cheng","year":"2021","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577794","article-title":"Insomnia and depressive behavior of MyD88-deficient mice: Relationships with altered microglial functions","volume":"363","author":"Choudhury","year":"2022","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0215","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: An update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0220","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hipo.23209","article-title":"Toll-like receptor 4 differentially regulates adult hippocampal neurogenesis in an age- and sex-dependent manner","volume":"30","author":"Connolly","year":"2020","journal-title":"Hippocampus"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0225","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbi.2017.04.006","article-title":"Toll like receptor 4 activation can be either detrimental or beneficial following mild repetitive traumatic brain injury depending on timing of activation","volume":"64","author":"Corrigan","year":"2017","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0230","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbi.2011.02.017","article-title":"The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity","volume":"25","author":"Cote","year":"2011","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0235","doi-asserted-by":"crossref","first-page":"ra45","DOI":"10.1126\/scisignal.2005965","article-title":"Activation of MyD88-dependent TLR1\/2 signaling by misfolded alpha-synuclein, a protein linked to neurodegenerative disorders","volume":"8","author":"Daniele","year":"2015","journal-title":"Science Signaling"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0240","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1073\/pnas.0510802103","article-title":"MyD88-dependent and -independent signaling by IL-1 in neurons probed by bifunctional toll\/IL-1 receptor domain\/BB-loop mimetics","volume":"103","author":"Davis","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0245","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/genes16101178","article-title":"Conserved blood transcriptome patterns highlight microRNA and hub gene drivers of neurodegeneration","volume":"16","author":"De La Cerna","year":"2025","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0250","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nprot.2006.120","article-title":"Housing, husbandry and handling of rodents for behavioral experiments","volume":"1","author":"Deacon","year":"2006","journal-title":"Nature Protocols"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0255","doi-asserted-by":"crossref","first-page":"97","DOI":"10.12703\/P6-97","article-title":"MyD88: A central player in innate immune signaling","volume":"6","author":"Deguine","year":"2014","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0260","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrn2822","article-title":"New neurons and new memories: How does adult hippocampal neurogenesis affect learning and memory?","volume":"11","author":"Deng","year":"2010","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0265","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/14728222.2018.1464139","article-title":"MyD88 as a therapeutic target for inflammatory lung diseases","volume":"22","author":"Di Padova","year":"2018","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152437","article-title":"Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson's disease","volume":"436","author":"Ding","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0280","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/0022034511400225","article-title":"LPS sensitizes TRPV1 via activation of TLR4 in trigeminal sensory neurons","volume":"90","author":"Diogenes","year":"2011","journal-title":"Journal of Dental Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0285","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1038\/s41380-020-0788-3","article-title":"Interleukin-1 receptor on hippocampal neurons drives social withdrawal and cognitive deficits after chronic social stress","volume":"26","author":"DiSabato","year":"2021","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0290","doi-asserted-by":"crossref","first-page":"9476","DOI":"10.1038\/s41598-018-27773-8","article-title":"Development of a novel backbone cyclic peptide inhibitor of the innate immune TLR\/IL1R signaling protein MyD88","volume":"8","author":"Dishon","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0295","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.tins.2020.07.008","article-title":"How do sensory neurons sense danger signals?","volume":"43","author":"Donnelly","year":"2020","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0300","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1742-2094-8-137","article-title":"The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration","volume":"8","author":"Drouin-Ouellet","year":"2011","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0305","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bbi.2012.02.007","article-title":"MyD88 deficiency results in both cognitive and motor impairments in mice","volume":"26","author":"Drouin-Ouellet","year":"2012","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0310","article-title":"Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson\u2019s disease","volume":"18","author":"Drouin-Ouellet","year":"2014","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0315","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1038\/s41467-021-25767-1","article-title":"Selective targeting of the TLR2\/MyD88\/NF-kappaB pathway reduces alpha-synuclein spreading in vitro and in vivo","volume":"12","author":"Dutta","year":"2021","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0320","doi-asserted-by":"crossref","first-page":"15247","DOI":"10.1073\/pnas.1314715110","article-title":"Activation of the canonical IKK complex by K63\/M1-linked hybrid ubiquitin chains","volume":"110","author":"Emmerich","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1334\u20131343","key":"10.1016\/j.pharmthera.2026.109016_bb0325","article-title":"The SARM1 toll\/Interleukin-1 receptor domain possesses intrinsic NAD(+) cleavage activity that promotes pathological axonal degeneration","volume":"93","author":"Essuman","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.921612","article-title":"Neuroinflammation involved in diabetes-related pain and itch","volume":"13","author":"Fang","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0335","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/jm070723u","article-title":"Design, synthesis, and in vitro activity of peptidomimetic inhibitors of myeloid differentiation factor 88","volume":"51","author":"Fanto","year":"2008","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104843","article-title":"Toll-like receptor signaling in depression","volume":"121","author":"Figueroa-Hall","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0345","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-024-07614-7","article-title":"Molecular definition of the endogenous toll-like receptor signalling pathways","volume":"631","author":"Fisch","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0350","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0355","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/35092578","article-title":"Mal (MyD88-adapter-like) is required for toll-like receptor-4 signal transduction","volume":"413","author":"Fitzgerald","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0360","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1083\/jcb.201607098","article-title":"Three-tier regulation of cell number plasticity by neurotrophins and tolls in Drosophila","volume":"216","author":"Foldi","year":"2017","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0365","doi-asserted-by":"crossref","first-page":"135","DOI":"10.31887\/DCNS.2004.6.2\/fgage","article-title":"Structural plasticity of the adult brain","volume":"6","author":"Gage","year":"2004","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0370","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1248\/bpb.32.1665","article-title":"Toll-like receptor 4-mediated myeloid differentiation factor 88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in hippocampal CA1 region in mice","volume":"32","author":"Gao","year":"2009","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0375","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.biopha.2008.06.028","article-title":"TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice","volume":"63","author":"Gao","year":"2009","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0380","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41590-017-0021-y","article-title":"Astrocytes decrease adult neurogenesis during virus-induced memory dysfunction via IL-1","volume":"19","author":"Garber","year":"2018","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0385","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1126\/science.1258366","article-title":"SARM1 activation triggers axon degeneration locally via NAD(+) destruction","volume":"348","author":"Gerdts","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0390","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/ajh.27666","article-title":"Waldenstrom Macroglobulinemia: 2025 update on diagnosis, risk stratification, and management","volume":"100","author":"Gertz","year":"2025","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110201","article-title":"BRG1 alleviates microglial activation by promoting the KEAP1-NRF2\/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia-reperfusion","volume":"119","author":"Guo","year":"2023","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0400","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/13651501.2013.859708","article-title":"The adapter proteins of TLRs, TRIF and MYD88, are upregulated in depressed individuals","volume":"18","author":"Hajebrahimi","year":"2014","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0405","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/brain\/awq325","article-title":"Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer\u2019s disease-related symptoms and pathology","volume":"134","author":"Hao","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0410","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","article-title":"The role of toll-like receptors and neuroinflammation in Parkinson\u2019s disease","volume":"19","author":"Heidari","year":"2022","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0415","doi-asserted-by":"crossref","first-page":"12618","DOI":"10.3390\/ijms232012618","article-title":"TLR4-pathway-associated biomarkers in subarachnoid hemorrhage (SAH): Potential targets for future anti-inflammatory therapies","volume":"23","author":"Heinz","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0420","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature03547","article-title":"Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction","volume":"434","author":"Honda","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0425","doi-asserted-by":"crossref","first-page":"15416","DOI":"10.1073\/pnas.0406933101","article-title":"Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in toll-like receptor signaling","volume":"101","author":"Honda","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0430","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbi.2019.04.033","article-title":"Neuroimmune interactions in chronic pain - an interdisciplinary perspective","volume":"79","author":"Hore","year":"2019","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0435","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.621446","article-title":"Possible involvement of MyD88 in regulating stress response in mice","volume":"15","author":"Hosoi","year":"2021","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0440","doi-asserted-by":"crossref","first-page":"44638","DOI":"10.1038\/srep44638","article-title":"TIR\/BB-loop mimetic AS-1 attenuates cardiac ischemia\/reperfusion injury via a caveolae and caveolin-3-dependent mechanism","volume":"7","author":"Hu","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0445","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1742-2094-8-42","article-title":"Genomic profile of toll-like receptor pathways in traumatically brain-injured mice: Effect of exogenous progesterone","volume":"8","author":"Hua","year":"2011","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108508","article-title":"miR-185-5p alleviates CCI-induced neuropathic pain by repressing NLRP3 inflammasome through dual targeting MyD88 and CXCR4","volume":"104","author":"Huang","year":"2022","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0455","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1111\/bph.15284","article-title":"Cytokine activin C ameliorates chronic neuropathic pain in peripheral nerve injury rodents by modulating the TRPV1 channel","volume":"177","author":"Huang","year":"2020","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0460","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-018-1907-y","article-title":"Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson\u2019s disease pathogenesis","volume":"137","author":"Hughes","year":"2019","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0465","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1083\/jcb.201712113","article-title":"Endosomal TLR3, TLR7, and TLR8 control neuronal morphology through different transcriptional programs","volume":"217","author":"Hung","year":"2018","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0470","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.neuroscience.2010.08.054","article-title":"Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia","volume":"171","author":"Hyakkoku","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0475","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-075037","article-title":"Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis","volume":"383","author":"Ilieva","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0480","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/j.pain.0000000000002454","article-title":"Dorsal root ganglion toll-like receptor 4 signaling contributes to oxaliplatin-induced peripheral neuropathy","volume":"163","author":"Illias","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0485","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaq1077","article-title":"Identification of toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins","volume":"11","author":"Ippagunta","year":"2018","journal-title":"Science Signaling"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0490","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC \u2013 A free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"Journal of Chemical Information and Modeling"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0495","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.4049\/jimmunol.181.10.7254","article-title":"Fibrillar amyloid-beta peptides activate microglia via TLR2: Implications for Alzheimer\u2019s disease","volume":"181","author":"Jana","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0500","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-5793(03)00747-6","article-title":"MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB- and AP-1-dependent gene expression","volume":"548","author":"Janssens","year":"2003","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0505","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd4334","article-title":"Emerging targets in neuroinflammation-driven chronic pain","volume":"13","author":"Ji","year":"2014","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107581","article-title":"Chemokines in chronic pain: Cellular and molecular mechanisms and therapeutic potential","volume":"212","author":"Jiang","year":"2020","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0515","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuroscience.2024.05.010","article-title":"MyD88 inhibition attenuates cerebral ischemia-reperfusion injury by regulating the inflammatory response and reducing blood-brain barrier damage","volume":"549","author":"Jiang","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0520","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/WNR.0000000000001608","article-title":"Deletion of MyD88 adaptor in nociceptor alleviates low-dose formalin-induced acute pain and persistent pain in mice","volume":"32","author":"Jiang","year":"2021","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0525","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202512375","article-title":"Neuronal endothelin a receptor mediates experimental and clinical vascular pain through an endothelial-neural Axis","volume":"12","author":"Jiang","year":"2025","journal-title":"Advanced Science"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0530","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.ejhg.5200415","article-title":"Two novel members of the interleukin-1 receptor gene family, one deleted in Xp22.1-Xp21.3 mental retardation","volume":"8","author":"Jin","year":"2000","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0535","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.cell.2007.09.008","article-title":"Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide","volume":"130","author":"Jin","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0540","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2021.08.018","article-title":"High-density lipoprotein in Alzheimer's disease: From potential biomarkers to therapeutics","volume":"338","author":"Jin","year":"2021","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0545","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11481-025-10202-9","article-title":"(+)-Catechin alleviates CCI-induced neuropathic pain by modulating microglia M1 and M2 polarization via the TLR4\/MyD88\/NF-kappaB signaling pathway","volume":"20","author":"Jing","year":"2025","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0550","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/glia.24285","article-title":"Deletion of MyD88 in astrocytes prevents beta-amyloid-induced neuropathology in mice","volume":"71","author":"Jong Huat","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0555","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41586-024-07220-7","article-title":"Formation of memory assemblies through the DNA-sensing TLR9 pathway","volume":"628","author":"Jovasevic","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0560","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0565","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.cell.2006.03.047","article-title":"Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling","volume":"125","author":"Kagan","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0570","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1083\/jcb.200705046","article-title":"MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis","volume":"179","author":"Kang","year":"2007","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037767","article-title":"Expression of toll-like receptors in the developing brain","volume":"7","author":"Kaul","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0580","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.smim.2006.12.004","article-title":"TLR signaling","volume":"19","author":"Kawai","year":"2007","journal-title":"Seminars in Immunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0585","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0590","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ni1118","article-title":"Interferon-alpha induction through toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6","volume":"5","author":"Kawai","year":"2004","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0595","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.852680","article-title":"What is adult hippocampal neurogenesis good for?","volume":"16","author":"Kempermann","year":"2022","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0600","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12974-018-1143-3","article-title":"Increased A20-E3 ubiquitin ligase interactions in bid-deficient glia attenuate TLR3- and TLR4-induced inflammation","volume":"15","author":"Kinsella","year":"2018","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0605","doi-asserted-by":"crossref","first-page":"31385","DOI":"10.1074\/jbc.M110.204982","article-title":"A small molecule that mimics the BB-loop in the toll interleukin-1 (IL-1) receptor domain of MyD88 attenuates staphylococcal enterotoxin B-induced pro-inflammatory cytokine production and toxicity in mice","volume":"286","author":"Kissner","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040773","article-title":"Therapeutic inhibition of pro-inflammatory signaling and toxicity to staphylococcal enterotoxin B by a synthetic dimeric BB-loop mimetic of MyD88","volume":"7","author":"Kissner","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0615","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cmet.2009.08.013","article-title":"MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity","volume":"10","author":"Kleinridders","year":"2009","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0620","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201912047","article-title":"SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration","volume":"219","author":"Ko","year":"2020","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0625","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2353\/ajpath.2007.060821","article-title":"Acute brain injury triggers MyD88-dependent, TLR2\/4-independent inflammatory responses","volume":"171","author":"Koedel","year":"2007","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0630","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1038\/s41418-018-0098-3","article-title":"Innate immune adaptor TRIF deficiency accelerates disease progression of ALS mice with accumulation of aberrantly activated astrocytes","volume":"25","author":"Komine","year":"2018","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0635","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ana.25698","article-title":"Toll-like receptor 4 signaling in neurons enhances calcium-permeable alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor currents and drives post-traumatic Epileptogenesis","volume":"87","author":"Korgaonkar","year":"2020","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0640","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bbi.2020.03.035","article-title":"Distinct cellular mediators drive the Janus faces of toll-like receptor 4 regulation of network excitability which impacts working memory performance after brain injury","volume":"88","author":"Korgaonkar","year":"2020","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0645","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbi.2019.06.042","article-title":"Toll-like receptors and their therapeutic potential in Parkinson\u2019s disease and alpha-synucleinopathies","volume":"81","author":"Kouli","year":"2019","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0650","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fneur.2017.00455","article-title":"Decreased secondary lesion growth and attenuated immune response after traumatic brain injury in Tlr2\/4(\u2212\/\u2212) mice","volume":"8","author":"Krieg","year":"2017","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0655","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fnins.2020.00075","article-title":"Brain structural plasticity: From adult neurogenesis to immature neurons","volume":"14","author":"La Rosa","year":"2020","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0660","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pharmthera.2017.10.006","article-title":"Toll-like receptors and their role in persistent pain","volume":"184","author":"Lacagnina","year":"2018","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0665","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: A generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere","year":"2009","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0670","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/ni1479","article-title":"Ligand-induced conformational changes allosterically activate toll-like receptor 9","volume":"8","author":"Latz","year":"2007","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0675","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/s41598-017-01998-5","article-title":"Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: A meta-analysis","volume":"7","author":"Lee","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0680","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2007.07.023","article-title":"Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia","volume":"190","author":"Lehnardt","year":"2007","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0685","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/TP.0000000000001471","article-title":"Short-term pharmacological inhibition of MyD88 Homodimerization by a novel inhibitor promotes robust allograft tolerance in mouse cardiac and skin transplantation","volume":"101","author":"Li","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0690","article-title":"A toll-receptor map underlies structural brain plasticity","volume":"9","author":"Li","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0695","article-title":"The toll route to structural brain plasticity","volume":"12","author":"Li","year":"2021","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0700","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2011.04.014","article-title":"Expression of myeloid differentiation primary response protein 88 (Myd88) in the cerebral cortex after experimental traumatic brain injury in rats","volume":"1396","author":"Li","year":"2011","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0705","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jss.2012.10.928","article-title":"Enhanced cortical expression of myeloid differentiation primary response protein 88 (Myd88) in patients with traumatic brain injury","volume":"180","author":"Li","year":"2013","journal-title":"The Journal of Surgical Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0710","first-page":"1322","article-title":"Botulinum neurotoxin a ameliorates depressive-like behavior in a reserpine-induced Parkinson\u2019s disease mouse model via suppressing hippocampal microglial engulfment and neuroinflammation","volume":"44","author":"Li","year":"2023","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0715","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jpain.2014.04.001","article-title":"Toll-like receptor 4 signaling contributes to paclitaxel-induced peripheral neuropathy","volume":"15","author":"Li","year":"2014","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0720","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1080438","article-title":"TJ-M2010-5, a novel CNS drug candidate, attenuates acute cerebral ischemia-reperfusion injury through the MyD88\/NF-kappaB and ERK pathway","volume":"13","author":"Li","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0725","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2147\/JPR.S487685","article-title":"Myeloid differentiation primary response protein 88: An important therapeutic target for chronic pain","volume":"18","author":"Liang","year":"2025","journal-title":"Journal of Pain Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0730","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ajpath.2011.05.045","article-title":"MyD88 deficiency ameliorates beta-amyloidosis in an animal model of Alzheimer\u2019s disease","volume":"179","author":"Lim","year":"2011","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0735","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbr.2011.10.027","article-title":"The effects of MyD88 deficiency on exploratory activity, anxiety, motor coordination, and spatial learning in C57BL\/6 and APPswe\/PS1dE9 mice","volume":"227","author":"Lim","year":"2012","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0740","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1753425913485877","article-title":"Neuronally-expressed Sarm1 regulates expression of inflammatory and antiviral cytokines in brains","volume":"20","author":"Lin","year":"2014","journal-title":"Innate Immunity"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0745","doi-asserted-by":"crossref","first-page":"12549","DOI":"10.1038\/srep12549","article-title":"Toll-like receptor 4 signaling in neurons of trigeminal ganglion contributes to nociception induced by acute pulpitis in rats","volume":"5","author":"Lin","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0750","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature09121","article-title":"Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR\/IL-1R signalling","volume":"465","author":"Lin","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0755","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12974-017-0822-9","article-title":"Suppression of MyD88-dependent signaling alleviates neuropathic pain induced by peripheral nerve injury in the rat","volume":"14","author":"Liu","year":"2017","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0760","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/FJC.0000000000000846","article-title":"Inhibition of MyD88 by LM8 attenuates obesity-induced cardiac injury","volume":"76","author":"Liu","year":"2020","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0765","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s12264-014-1445-5","article-title":"Innate immune responses regulate morphogenesis and degeneration: Roles of toll-like receptors and Sarm1 in neurons","volume":"30","author":"Liu","year":"2014","journal-title":"Neuroscience Bulletin"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0770","doi-asserted-by":"crossref","first-page":"11479","DOI":"10.1523\/JNEUROSCI.5566-12.2013","article-title":"TLR7 negatively regulates dendrite outgrowth through the Myd88-c-Fos-IL-6 pathway","volume":"33","author":"Liu","year":"2013","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0775","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/hepr.13359","article-title":"Implication of myeloid differentiation factor 88 inhibitor TJ-M2010-5 for therapeutic intervention of hepatocellular carcinoma","volume":"49","author":"Liu","year":"2019","journal-title":"Hepatology Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0780","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1126\/science.1155406","article-title":"Structural basis of toll-like receptor 3 signaling with double-stranded RNA","volume":"320","author":"Liu","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0785","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00011-023-01801-4","article-title":"Targeting MyD88: Therapeutic mechanisms and potential applications of the specific inhibitor ST2825","volume":"72","author":"Liu","year":"2023","journal-title":"Inflammation Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0790","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6016272","article-title":"Activation of GABA(B) receptor suppresses diabetic neuropathic pain through toll-like receptor 4 signaling pathway in the spinal dorsal horn","volume":"2018","author":"Liu","year":"2018","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0795","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1172\/JCI45414","article-title":"TLR3 deficiency impairs spinal cord synaptic transmission, central sensitization, and pruritus in mice","volume":"122","author":"Liu","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0800","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/nn.2683","article-title":"Toll-like receptor 7 mediates pruritus","volume":"13","author":"Liu","year":"2010","journal-title":"Nature Neuroscience"},{"issue":"317\u2013333","key":"10.1016\/j.pharmthera.2026.109016_bb0805","article-title":"Cell-type-specific interleukin 1 receptor 1 signaling in the brain regulates distinct Neuroimmune activities","volume":"50","author":"Liu","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0810","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fneur.2018.00008","article-title":"Microglia and CNS Interleukin-1: Beyond immunological concepts","volume":"9","author":"Liu","year":"2018","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0815","doi-asserted-by":"crossref","first-page":"28188","DOI":"10.1038\/srep28188","article-title":"TLR signaling adaptor protein MyD88 in primary sensory neurons contributes to persistent inflammatory and neuropathic pain and neuroinflammation","volume":"6","author":"Liu","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0820","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/awr350","article-title":"Activin C expressed in nociceptive afferent neurons is required for suppressing inflammatory pain","volume":"135","author":"Liu","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0825","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/cr.2014.106","article-title":"Nociceptive neurons regulate innate and adaptive immunity and neuropathic pain through MyD88 adapter","volume":"24","author":"Liu","year":"2014","journal-title":"Cell Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0830","doi-asserted-by":"crossref","first-page":"12982","DOI":"10.1523\/JNEUROSCI.1348-14.2014","article-title":"IKKbeta deficiency in myeloid cells ameliorates Alzheimer\u2019s disease-related symptoms and pathology","volume":"34","author":"Liu","year":"2014","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0835","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1189\/jlb.1206746","article-title":"Pivotal advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound","volume":"82","author":"Loiarro","year":"2007","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0840","doi-asserted-by":"crossref","first-page":"15809","DOI":"10.1074\/jbc.C400613200","article-title":"Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-kappaB","volume":"280","author":"Loiarro","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0845","first-page":"1095","article-title":"Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6","volume":"5","author":"Lord","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0850","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1471-4159.2005.03188.x","article-title":"Amyloid beta peptide 1-40 enhances the action of toll-like receptor-2 and -4 agonists but antagonizes toll-like receptor-9-induced inflammation in primary mouse microglial cell cultures","volume":"94","author":"Lotz","year":"2005","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0855","article-title":"Neuroinflammation in HIV-related neuropathic pain","volume":"12","author":"Lu","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0860","doi-asserted-by":"crossref","first-page":"10486","DOI":"10.1038\/s41467-025-65454-z","article-title":"State-selective small molecule degraders that preferentially remove aggregates and oligomers","volume":"16","author":"Luptak","year":"2025","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0865","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1742-2094-11-114","article-title":"Interleukin-1 beta guides the migration of cortical neurons","volume":"11","author":"Ma","year":"2014","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0870","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1474-4422(22)00309-X","article-title":"Traumatic brain injury: Progress and challenges in prevention, clinical care, and research","volume":"21","author":"Maas","year":"2022","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0875","first-page":"38130","article-title":"Molecular pathogenesis of ischemic and hemorrhagic strokes: Background and therapeutic approaches","volume":"24","author":"Maida","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0880","article-title":"Structural basis for TIR domain-mediated innate immune signaling by toll-like receptor adaptors TRIF and TRAM","volume":"122","author":"Manik","year":"2025","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0885","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/imcb.12816","article-title":"Myddosomes in toll-like receptor signaling-one to bind and rule them all","volume":"102","author":"Mathmann","year":"2024","journal-title":"Immunology and Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0890","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nn.3474","article-title":"Toll-6 and Toll-7 function as neurotrophin receptors in the Drosophila melanogaster CNS","volume":"16","author":"McIlroy","year":"2013","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0895","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11916-017-0629-5","article-title":"Neuropathic pain: Central vs. peripheral mechanisms","volume":"21","author":"Meacham","year":"2017","journal-title":"Current Pain and Headache Reports"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0900","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1097-2765(00)80136-7","article-title":"MyD88 is an adaptor protein in the hToll\/IL-1 receptor family signaling pathways","volume":"2","author":"Medzhitov","year":"1998","journal-title":"Molecular Cell"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0905","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1326-6-5","article-title":"MyD88-adaptor protein acts as a preventive mechanism for memory deficits in a mouse model of Alzheimer\u2019s disease","volume":"6","author":"Michaud","year":"2011","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0910","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12974-015-0263-2","article-title":"Soluble amyloid triggers a myeloid differentiation factor 88 and interferon regulatory factor 7 dependent neuronal type-1 interferon response in vitro","volume":"12","author":"Minter","year":"2015","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0915","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s11011-021-00806-4","article-title":"Neuroinflammation in neurological disorders: Pharmacotherapeutic targets from bench to bedside","volume":"36","author":"Mishra","year":"2021","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0920","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/HYPERTENSIONAHA.118.12595","article-title":"TLR4 (toll-like receptor 4) mediates the development of intracranial aneurysm rupture","volume":"75","author":"Mitsui","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0925","doi-asserted-by":"crossref","first-page":"25404","DOI":"10.1074\/jbc.M109.022392","article-title":"An oligomeric signaling platform formed by the toll-like receptor signal transducers MyD88 and IRAK-4","volume":"284","author":"Motshwene","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0930","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.278.5343.1612","article-title":"IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling","volume":"278","author":"Muzio","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0935","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10495-014-1073-1","article-title":"Toll\/interleukin-1 receptor (TIR) domain-mediated cellular signaling pathways","volume":"20","author":"Narayanan","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0940","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/bloodadvances.2018027672","article-title":"MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas","volume":"3","author":"Nayyar","year":"2019","journal-title":"Blood Advances"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0945","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.expneurol.2011.09.038","article-title":"Toll-like receptors in chronic pain","volume":"234","author":"Nicotra","year":"2012","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0950","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/srep01393","article-title":"Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease","volume":"3","author":"Noelker","year":"2013","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0955","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.mcn.2011.07.003","article-title":"IL-1beta inhibits axonal growth of developing sympathetic neurons","volume":"48","author":"Nolan","year":"2011","journal-title":"Molecular and Cellular Neurosciences"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0960","doi-asserted-by":"crossref","first-page":"10260","DOI":"10.1073\/pnas.0812956106","article-title":"Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling","volume":"106","author":"Ohnishi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0965","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1471-4159.2010.06778.x","article-title":"TLR2 activation inhibits embryonic neural progenitor cell proliferation","volume":"114","author":"Okun","year":"2010","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0970","doi-asserted-by":"crossref","first-page":"14246","DOI":"10.1038\/srep14246","article-title":"Discovery of small molecule inhibitors of MyD88-dependent signaling pathways using a computational screen","volume":"5","author":"Olson","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0975","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2079","article-title":"The family of five: TIR-domain-containing adaptors in toll-like receptor signalling","volume":"7","author":"O\u2019Neill","year":"2007","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0980","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2468-2667(21)00230-9","article-title":"Primary stroke prevention worldwide: Translating evidence into action","volume":"7","author":"Owolabi","year":"2022","journal-title":"The Lancet Public Health"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0985","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fnsyn.2017.00009","article-title":"Function and dysfunction of microglia during brain development: Consequences for synapses and neural circuits","volume":"9","author":"Paolicelli","year":"2017","journal-title":"Frontiers in Synaptic Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0990","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/iub.2510","article-title":"Toll-like receptors in neuroinflammation, neurodegeneration, and alcohol-induced brain damage","volume":"73","author":"Pascual","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.pharmthera.2026.109016_bb0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111225","article-title":"The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways","volume":"40","author":"Pereira","year":"2022","journal-title":"Cell Reports"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1000","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10072-018-3592-y","article-title":"Vinpocetine regulates levels of circulating TLRs in Parkinson's disease patients","volume":"40","author":"Ping","year":"2019","journal-title":"Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12964-021-00811-1","article-title":"Mechanism of MyD88S mediated signal termination","volume":"20","author":"Pustelny","year":"2022","journal-title":"Cell Communication and Signaling: CCS"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1010","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.4049\/jimmunol.1001241","article-title":"Painful pathways induced by TLR stimulation of dorsal root ganglion neurons","volume":"186","author":"Qi","year":"2011","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1015","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1161\/STROKEAHA.110.590463","article-title":"High-mobility group box 1 promotes metalloproteinase-9 upregulation through toll-like receptor 4 after cerebral ischemia","volume":"41","author":"Qiu","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1020","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/glia.24007","article-title":"Haploinsufficiency of microglial MyD88 ameliorates Alzheimer\u2019s pathology and vascular disorders in APP\/PS1-transgenic mice","volume":"69","author":"Quan","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1025","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s00044-022-02861-7","article-title":"Design and synthesis of novel pyrazolopyrimidine-based derivatives as reversible BTK inhibitors with potent antiproliferative activity in mantle cell lymphoma","volume":"31","author":"Ran","year":"2022","journal-title":"Medicinal Chemistry Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1030","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1172\/JCI96209","article-title":"Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer\u2019s pathology","volume":"128","author":"Rangasamy","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1035","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1523\/JNEUROSCI.1146-08.2008","article-title":"Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer\u2019s disease","volume":"28","author":"Richard","year":"2008","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1040","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1097\/j.pain.0000000000003238","article-title":"Nociplastic pain mechanisms and toll-like receptors as promising targets for its management","volume":"165","author":"Rodriguez-Palma","year":"2024","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1045","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/ncb1629","article-title":"Toll-like receptors modulate adult hippocampal neurogenesis","volume":"9","author":"Rolls","year":"2007","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1050","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1073\/pnas.1017820108","article-title":"Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism","volume":"108","author":"Ros-Bernal","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41572-023-00484-9","article-title":"Central neuropathic pain","volume":"9","author":"Rosner","year":"2023","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12026-021-09188-2","article-title":"MyD88 and beyond: A perspective on MyD88-targeted therapeutic approach for modulation of host immunity","volume":"69","author":"Saikh","year":"2021","journal-title":"Immunologic Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1065","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.3390\/ijms25158421","article-title":"Targeting myeloid differentiation primary response protein 88 (MyD88) and Galectin-3 to develop broad-Spectrum host-mediated therapeutics against SARS-CoV-2","volume":"25","author":"Saikh","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1070","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104854","article-title":"A small molecule inhibitor of MyD88 exhibits broad spectrum antiviral activity by up regulation of type I interferon","volume":"181","author":"Saikh","year":"2020","journal-title":"Antiviral Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbi.2020.09.024","article-title":"Abnormal brain structure and behavior in MyD88-deficient mice","volume":"91","author":"Schroeder","year":"2021","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neuropharm.2018.07.022","article-title":"Role of toll-like receptor mediated signaling in traumatic brain injury","volume":"145","author":"Shi","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1085","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S1474-4422(19)30078-X","article-title":"Global brain inflammation in stroke","volume":"18","author":"Shi","year":"2019","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","article-title":"The far-reaching scope of neuroinflammation after traumatic brain injury","volume":"13","author":"Simon","year":"2017","journal-title":"Nature Reviews. Neurology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1074-7613(02)00514-9","article-title":"The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action","volume":"18","author":"Smith","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.775117","article-title":"Discovery of a novel MyD88 inhibitor M20 and its protection against Sepsis-mediated acute lung injury","volume":"12","author":"Song","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1105","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/biom14050562","article-title":"MyD88 and its inhibitors in Cancer: Prospects and challenges","volume":"14","author":"Song","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1110","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.tips.2022.05.004","article-title":"Toll-like receptor-mediated neuroinflammation: Relevance for cognitive dysfunctions","volume":"43","author":"Squillace","year":"2022","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1742-2094-10-148","article-title":"Toll-like receptor signaling adapter proteins govern spread of neuropathic pain and recovery following nerve injury in male mice","volume":"10","author":"Stokes","year":"2013","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1120","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918754612","article-title":"Inhibition of toll-like receptor 4 alleviates hyperalgesia induced by acute dural inflammation in experimental migraine","volume":"14","author":"Su","year":"2018","journal-title":"Molecular Pain"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12974-020-02066-y","article-title":"Suppression of TLR4-MyD88 signaling pathway attenuated chronic mechanical pain in a rat model of endometriosis","volume":"18","author":"Su","year":"2021","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1130","doi-asserted-by":"crossref","first-page":"12871","DOI":"10.1073\/pnas.202396399","article-title":"A heterotrimeric death domain complex in toll signaling","volume":"99","author":"Sun","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1135","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.brainres.2013.05.010","article-title":"Expression and cell distribution of myeloid differentiation primary response protein 88 in the cerebral cortex following experimental subarachnoid hemorrhage in rats: A pilot study","volume":"1520","author":"Sun","year":"2013","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1140","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature736","article-title":"Severe impairment of interleukin-1 and toll-like receptor signalling in mice lacking IRAK-4","volume":"416","author":"Suzuki","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature03308","article-title":"Integral role of IRF-5 in the gene induction programme activated by toll-like receptors","volume":"434","author":"Takaoka","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41408-023-00902-x","article-title":"Zanubrutinib: Past, present, and future","volume":"13","author":"Tam","year":"2023","journal-title":"Blood Cancer Journal"},{"issue":"384\u2013398","key":"10.1016\/j.pharmthera.2026.109016_bb1155","article-title":"Innate immune signaling organelles display natural and programmable signaling flexibility","volume":"177","author":"Tan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147332","article-title":"Evolutionary and functional conservation of myeloid differentiation factor 88 (MyD88) in amphibian Xenopus tropicalis","volume":"865","author":"Tang","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1165","doi-asserted-by":"crossref","first-page":"13798","DOI":"10.1073\/pnas.0702553104","article-title":"Pivotal role for neuronal toll-like receptors in ischemic brain injury and functional deficits","volume":"104","author":"Tang","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.expneurol.2008.05.014","article-title":"Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal","volume":"213","author":"Tang","year":"2008","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1175","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1126\/science.1229159","article-title":"Structural reorganization of the toll-like receptor 8 dimer induced by agonistic ligands","volume":"339","author":"Tanji","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1180","doi-asserted-by":"crossref","DOI":"10.1016\/j.gde.2025.102339","article-title":"Recent advances in RNA-based therapeutics for neurodevelopmental disorders","volume":"92","author":"Tirumala","year":"2025","journal-title":"Current Opinion in Genetics & Development"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1185","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4049\/jimmunol.175.1.494","article-title":"Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction","volume":"175","author":"Toshchakov","year":"2005","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1190","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstrom\u2019s macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1195","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1126\/science.aal3589","article-title":"Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development","volume":"359","author":"Vainchtein","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1200","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s10495-014-1064-2","article-title":"Structure and function of toll\/interleukin-1 receptor\/resistance protein (TIR) domains","volume":"20","author":"Ve","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1189\/jlb.3MR0416-204R","article-title":"Danger-associated molecular patterns in Alzheimer\u2019s disease","volume":"101","author":"Venegas","year":"2017","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105222","article-title":"Chronic pain and neuroinflammation","volume":"88","author":"Vergne-Salle","year":"2021","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1215","article-title":"Endothelin a receptor in nociceptors is essential for persistent mechanical pain in a chronic pancreatitis of mouse model","volume":"31","author":"Wang","year":"2025","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1220","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/35085597","article-title":"TAK1 is a ubiquitin-dependent kinase of MKK and IKK","volume":"412","author":"Wang","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1225","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.expneurol.2017.05.008","article-title":"Myeloid differentiation factor 88 is up-regulated in epileptic brain and contributes to experimental seizures in rats","volume":"295","author":"Wang","year":"2017","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1230","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuroscience.2020.01.010","article-title":"Activation of different heterodimers of TLR2 distinctly mediates pain and itch","volume":"429","author":"Wang","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1235","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.4049\/jimmunol.0900762","article-title":"Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner","volume":"183","author":"Wang","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1240","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106133","article-title":"CD44 deficiency represses neuroinflammation and rescues dopaminergic neurons in a mouse model of Parkinson's disease","volume":"177","author":"Wang","year":"2022","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1245","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.24159","article-title":"Toll-like receptor 2\/4 heterodimer mediates inflammatory injury in intracerebral hemorrhage","volume":"75","author":"Wang","year":"2014","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1250","article-title":"Targeting the AKT-P53\/CREB pathway with epicatechin for improved prognosis of traumatic brain injury","volume":"30","author":"Wang","year":"2024","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1255","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110968","article-title":"Traditional Chinese medicine compounds regulate autophagy for treating neurodegenerative disease: A mechanism review","volume":"133","author":"Wang","year":"2021","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1260","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.neuron.2015.02.003","article-title":"Toll receptors instruct axon and dendrite targeting and participate in synaptic partner matching in a Drosophila olfactory circuit","volume":"85","author":"Ward","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1265","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.ajpath.2014.07.004","article-title":"MyD88 is dispensable for cerebral amyloidosis and neuroinflammation in APP\/PS1 transgenic mice","volume":"184","author":"Weitz","year":"2014","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1270","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7924199","article-title":"Toll-like receptor 4: A promising therapeutic target for Alzheimer\u2019s disease","volume":"2022","author":"Wu","year":"2022","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1275","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1515\/revneuro-2014-0067","article-title":"Role of toll-like receptor\/MYD88 signaling in neurodegenerative diseases","volume":"26","author":"Xiang","year":"2015","journal-title":"Reviews in the Neurosciences"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1280","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv364","article-title":"Targeting of MyD88 Homodimerization by novel synthetic inhibitor TJ-M2010-5 in preventing colitis-associated colorectal Cancer","volume":"108","author":"Xie","year":"2016","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1285","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1142\/S0219635214500216","article-title":"Chronic morphine treatment increased the expression of myeloid differentiation primary response protein 88 in rat spinal cord","volume":"13","author":"Xu","year":"2014","journal-title":"Journal of Integrative Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1290","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/35040600","article-title":"Structural basis for signal transduction by the toll\/interleukin-1 receptor domains","volume":"408","author":"Xu","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1295","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.18632\/aging.202503","article-title":"Sleep deprivation aggravates brain injury after experimental subarachnoid hemorrhage via TLR4-MyD88 pathway","volume":"13","author":"Xu","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1300","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/nm.3978","article-title":"Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade","volume":"21","author":"Xu","year":"2015","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1305","doi-asserted-by":"crossref","first-page":"15797","DOI":"10.1038\/s41598-017-16124-8","article-title":"Inhibition of myeloid differentiation primary response protein 88 provides neuroprotection in early brain injury following experimental subarachnoid hemorrhage","volume":"7","author":"Yan","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1310","doi-asserted-by":"crossref","first-page":"18040","DOI":"10.1021\/acs.jmedchem.5c01019","article-title":"Small-molecule ligands targeting lysosome-shuttling receptors and the emerging landscape of lysosome-targeting chimeras","volume":"68","author":"Yang","year":"2025","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1315","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14412","article-title":"Human umbilical cord derived mesenchymal stem cells overexpressing HO-1 attenuate neural injury and enhance functional recovery by inhibiting inflammation in stroke mice","volume":"30","author":"Yang","year":"2024","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1320","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneuroim.2017.06.006","article-title":"TLR4 signal ablation attenuated neurological deficits by regulating microglial M1\/M2 phenotype after traumatic brain injury in mice","volume":"310","author":"Yao","year":"2017","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1325","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1111\/j.1582-4934.2010.01127.x","article-title":"Endogenous toll-like receptor ligands and their biological significance","volume":"14","author":"Yu","year":"2010","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1330","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-18-0215","article-title":"MYD88 L265P mutation in lymphoid malignancies","volume":"78","author":"Yu","year":"2018","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1335","first-page":"26","article-title":"Genetic ablation of toll-like receptor 2 reduces secondary brain injury caused by cortical contusion in mice","volume":"42","author":"Yu","year":"2012","journal-title":"Annals of Clinical and Laboratory Science"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1340","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41577-020-00487-7","article-title":"Innate immunity at the crossroads of healthy brain maturation and neurodevelopmental disorders","volume":"21","author":"Zengeler","year":"2021","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1345","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2147\/IJN.S400798","article-title":"Sustained-release Esketamine based nanoparticle-hydrogel delivery system for neuropathic pain management","volume":"18","author":"Zhang","year":"2023","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1350","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2016.05.003","article-title":"Inhibition of myeloid differentiation factor 88(MyD88) by ST2825 provides neuroprotection after experimental traumatic brain injury in mice","volume":"1643","author":"Zhang","year":"2016","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1355","doi-asserted-by":"crossref","first-page":"26954","DOI":"10.1038\/srep26954","article-title":"Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro","volume":"6","author":"Zhang","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1360","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110863","article-title":"Compound c17 alleviates inflammatory cardiomyopathy in streptozotocin-induced diabetic mice by targeting MyD88","volume":"124","author":"Zhang","year":"2023","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1365","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41401-021-00766-6","article-title":"Pharmacological inhibition of MyD88 suppresses inflammation in tubular epithelial cells and prevents diabetic nephropathy in experimental mice","volume":"43","author":"Zhang","year":"2022","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1370","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.3390\/molecules27092990","article-title":"ST2825, a small molecule inhibitor of MyD88, suppresses NF-kappaB activation and the ROS\/NLRP3\/cleaved Caspase-1 signaling pathway to attenuate lipopolysaccharide-stimulated Neuroinflammation","volume":"27","author":"Zhang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1375","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1380","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.metabol.2016.05.005","article-title":"Beyond knockout: A novel homodimerization-targeting MyD88 inhibitor prevents and cures type 1 diabetes in NOD mice","volume":"65","author":"Zhang","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1385","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000326771","article-title":"Immunolocalization of toll-like receptors 2 and 4 as well as their endogenous ligand, heat shock protein 70, in rat traumatic brain injury","volume":"19","author":"Zhang","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1390","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1084\/jem.20180800","article-title":"TLR8 and its endogenous ligand miR-21 contribute to neuropathic pain in murine DRG","volume":"215","author":"Zhang","year":"2018","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1395","article-title":"Neuroinflammation following traumatic brain injury: Take it seriously or not","volume":"13","author":"Zheng","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1400","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41401-020-0410-x","article-title":"Compound LM9, a novel MyD88 inhibitor, efficiently mitigates inflammatory responses and fibrosis in obesity-induced cardiomyopathy","volume":"41","author":"Zheng","year":"2020","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1405","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bbrc.2007.05.157","article-title":"TLR2 has a detrimental role in mouse transient focal cerebral ischemia","volume":"359","author":"Ziegler","year":"2007","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2026.109016_bb1410","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116971","article-title":"GPR40 inhibits microglia-mediated neuroinflammation via the NLRP3\/IL-1beta\/glutaminase pathway after subarachnoid hemorrhage","volume":"238","author":"Zou","year":"2025","journal-title":"Biochemical Pharmacology"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826000434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826000434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:09:41Z","timestamp":1776434981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725826000434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":282,"alternative-id":["S0163725826000434"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109016","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of MyD88 in the nervous system: Neuronal functions, implications in neurological diseases, and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109016"}}